We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

c-MER Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant human c-MER (amino acids 578–872) was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. c-MER is a tyrosine kinase and a member of the MER/AXL/TYRO3 receptor kinase family. The c-MER gene encodes a transmembrane protein with two fibronectin type-III domains, two Ig-like C2-type domains and one tyrosine kinase domain. Functional knockout of c-MER in mice shows the mice to have macrophages deficient in the clearance of apoptotic thymocytes thereby demonstrating the critical role for c-MER in the engulfment and efficient clearance of apoptotic cells. ...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for US customers only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

c-MER Kinase Enzyme System

Close Window

c-MER Kinase Enzyme System

 Components

10μg
- V3541 $ 406.00 Add to cart

c-MER Kinase Enzyme System

Close Window

c-MER Kinase Enzyme System

 Components

1mg
- V3542 $ 5,990.00 Add to cart

ADP-Glo™ Kinase Assay + c-MER Kinase Enzyme System

Close Window

ADP-Glo™ Kinase Assay + c-MER Kinase Enzyme System

 Components

  • c-MER Kinase Enzyme System

    V35411 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V9561 $ 808.00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V3541, V3542, V9561 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V9561 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V9561 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V9561 U.S. Pat. No. 7,741,067 and other patents and patents pending.

V9561 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V9561 U.S. Pat. No. 8,183,007 and other patents pending.

V9561 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V9561 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.